NCT06968455View on ClinicalTrials.gov

Endocrine Disruptors, Toxic and Essential Chemical Elements and Polycystic Ovary Syndrome

CompletedOBSERVATIONAL

Enrollment

70

Participants

Timeline

Start Date

January 3, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Polycystic Ovary Syndrome

Interventions

OTHER

parabens

endocrine disruptors

Trial Locations (1)

1000

Division of Ob/Gyn, University Medical Centre Ljubljana, Ljubljana

All Listed Sponsors

lead

University Medical Centre Ljubljana

OTHER